Inogen develops, manufactures, and markets portable oxygen concentrators for patients, physicians, and payors globally. Its concentrators deliver supplemental long-term oxygen therapy to chronic respiratory condition patients. The company offers portable Inogen One devices, stationary At Home units, airway clearance systems, batteries, and accessories. It also rents products directly to patients.
| Indicator | Value |
|---|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | 3.1% |
| Net Debt/EBITDA | 4.4 |